Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968305 · ClinicalTrials.gov registry record
Interleukin (IL)-13 as a Marker in Pediatrics Asthma
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 19
- Enrollment target
NCT00968305 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 19 participants.
The verdict
NCT00968305 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Asthma is a very common childhood chronic illness and is generally more severe in African Americans. The investigators attempted to determine whether a specific immune marker is associated with lung function and asthma severity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00968305
The ClinicalTrials.gov registry entry for NCT00968305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00968305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00968305 about?
NCT00968305 is a clinical study titled "Interleukin (IL)-13 as a Marker in Pediatrics Asthma". Asthma is a very common childhood chronic illness and is generally more severe in African Americans. The investigators attempted to determine whether a specific immune marker is associated with lung function and asthma severity.
What is the current status of trial NCT00968305?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2008-11. Estimated completion is 2009-08.
Who is sponsoring clinical trial NCT00968305?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.